RE:CXRX options - FEB $5 calls over 3,000 contracts outAppears to be some lift in all pharma today, vrx and endo as well are getting a noteworthy boost.
Canaccord has one dollar on cxrx, RBC has one dollar, Scotia has 50 cents. I Expect some analysts to stop covering Concordia management doesn't offer guidance or forward EBITDA soon. The Press release language seems to indicate this is the last communication for a while "We look forward to providing a progress update during our regularly year end reporting antiicpated in March, 2017" I don't believe institutions will buy in without any guidance as investors need to know that they can service the debt. If they had 490million Sept 30 and now they have 410million, then its obvious they really needed the Goldman $ and have made zero on operations. But what the market decides is anyone's guess but any gain today barely puts a dent in the stocks fall - and in the past any gain has been wiped out in a very short time.
Walter1000 wrote: calls Offered at .10 US
What price target does Canaccord Genuity have on this broken down roll up?
There are lots of puts at $2.50 as well. If the stock gets above $5 in Q1, it will get mighty interesting to see the dazzling panic that unfolds. About the same time as Trump swearing in. Being forwarned is forarmed.